Thorac Cardiovasc Surg 2020; 68(01): 068-071
DOI: 10.1055/s-0039-1697914
How to do it
Georg Thieme Verlag KG Stuttgart · New York

Intermuscular S-ICD Implantation in Pediatric Patients

Authors

  • Andrea Ferreiro-Marzal*

    1   Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
  • Fernando Rodríguez-Serrano*

    2   Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, Granada, Spain
    3   Biosanitary Research Institute of Granada (ibs.GRANADA), Granada, Spain
  • María Esteban-Molina

    1   Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
  • Teresa González-Vargas

    1   Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
  • Francesca Perin

    4   Pediatric Cardiology Unit, Virgen de las Nieves University Hospital, Granada, Spain
  • Jose Manuel Garrido

    1   Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
    2   Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, Granada, Spain
    3   Biosanitary Research Institute of Granada (ibs.GRANADA), Granada, Spain
    5   Department of Surgery and its Specialities, Universidad de Granada, Granada, Spain
Weitere Informationen

Publikationsverlauf

20. Februar 2019

07. August 2019

Publikationsdatum:
20. Oktober 2019 (online)

Preview

Abstract

The use of conventional implantable cardioverter-defibrillators (ICDs) in children presents important technical challenges. We present the surgical technique necessary to adapt the subcutaneous ICD (S-ICD) implantation designed for adults, to children, including patients weighing less than 20 kg. The implant procedure implies a two-incision technique and interfascial serratus anterior–latissimus dorsi dissection to accommodate the device. S-ICD implantation was successfully performed in three patients of 19, 28, and 24 kg, respectively, two of them suffered cardiorespiratory arrest. Intermuscular thoracic implantation of S-ICD might represent an effective strategy for primary or secondary prevention of sudden cardiac death in pediatric patients.

* Both authors contributed equally to this work.